- Home
- About Us
- Programs
- After Hours Initiative
- Chronic Disease Prevention and Management
- Coordinated Veterans’ Care
- eHealth and Information Management
- Effective Resource Management
- Indigenous Health
- Immunisation
- Lifescripts
- Mind the Gap
- National Primary Mental Health Program
- Nursing in General Practice
- Quality Use of Medicines (QUM)
- Rural Palliative Care Project
- Policy
- Media
- Transition
Programs
ATAGI updates their recommendations for revaccination of adults with 23vPPV
ATAGI has reviewed available evidence on the safety, efficacy and effectiveness of the 23vPPV and its place within the national Immunisation Program (NIP). A definite modest level of protection against invasive pneumococcal disease (IPD) is afforded by 23vPPV for adults and older adults. Whilst systemic and local reactions after 23vPPV are common, local reactions occur more commonly in repeat dose recipients compared with first dose recipients. In light of this, ATAGI recommends that a second dose is no longer applicable for those without any condition that predisposes them to an increased risk of IPD.
Click here for more details.
Copyright © 2010 Australian General Practice Network.
Address: Ground Floor, Minter Ellison Building, 25 National Circuit, Forrest ACT 2601
Postal Address: PO Box 4308, Manuka ACT 2603
Phone: 02 6228 0800 | Fax: 02 6228 0899 | Email: agpnreception@agpn.com.au
ABN: 95 082 812 146